SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-130984
Filing Date
2022-12-29
Accepted
2022-12-29 17:03:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2233672d1_424b5.htm 424B5 853777
2 GRAPHIC tm2123734d1_424b5img003.jpg GRAPHIC 3498
3 GRAPHIC tm2233672d1_424b5img001.jpg GRAPHIC 11518
4 GRAPHIC tm2233672d1_424b5img002.jpg GRAPHIC 11483
  Complete submission text file 0001104659-22-130984.txt   892012
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-254980 | Film No.: 221499428
SIC: 2834 Pharmaceutical Preparations